All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-EGFR DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-0771-CQ | 5BA23 | Mouse | Human | IgG1, κ | Synthetic Peptide (GSHQISLDNPDYQQDFFPK (C-terminus aa 1161-1179)) | |
DMAb-3301-FY | 111.6 | Mouse | IgG1 | |||
DMAb-3302-FY | 13G8 | Mouse | IgG1 | Peptide conjugated to KLH | ||
DMAb-3303-FY | 30H45L48 | Rabbit | Human | IgG | ||
DMAb-3304-FY | 31G7 | Mouse | Human | IgG1, κ | Human EGF Receptor purified from A431 cells was used as the immunogen for the EGFR antibody | |
DMAb-3305-FY | 3H2093 | Rat | Human | IgG2b | Breast carcinoma cells | |
DMAb-3306-FY | 3H2094 | Mouse | Human | IgG1 | Synthetic peptide sequence DVVDADEYLIPQ residues 985-996 from the sequence of the human EGF receptor | |
DMAb-3307-FY | 423103 | Rat | Human | IgG2a | Mouse myeloma cell line NS0-derived recombinant human EGF R/ErbB1, Leu25-Ser645 | |
DMAb-3308-FY | 5E10D3 | Mouse | Human | IgG2b | Purified recombinant fragment of human EGFR expressed in E.coli | |
DMAb-3309-FY | 5E10-G10-E11 | Mouse | IgG1 | |||
DMAb-3310-FY | 5G9B5 | Mouse | Human | IgG1 | ||
DMAb-3311-FY | 688CT33.1.3 | Mouse | Human | IgG1 | This EGFR antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 1163-1191 amino acids from the C-terminal region of human EGFR | |
DMAb-3312-FY | 7A6F12 | Mouse | Human | IgG1 | Recombinant fragment of human EGFR expressed in E.coli | |
DMAb-3313-FY | AT2H8 | Mouse | Human | IgG2b, κ | Recombinant human EGFR purified from E coli | |
DMAb-3314-FY | D38B1 | Rabbit | ||||
DMAb-3315-FY | DH8.3 | Mouse | Human | IgG1 | Synthetic peptide corresponding to the junctional region of the truncated receptor LEEKKGNYVVTDHC, conjugated to keyhole limpet haemcyanin | |
DMAb-3316-FY | EGFR.1 | Mouse | Human | IgG2b, κ | ||
DMAb-3317-FY | EGFR1 | Mouse | Human | IgG2b | Human epidermoid carcinoma line A431 | |
DMAb-3318-FY | EP38Y | Rabbit | IgG | |||
DMAb-3319-FY | ERB7-1 | Mouse | Human | IgG1, κ | Purified EGF receptor was used as the immunogen for the EGFR antibody | |
DMAb-3320-FY | GFR/1667 | Mouse | Human | IgG1 | Recombinant human full-length EGFR protein | |
DMAb-3321-FY | GFR1195 | Mouse | Human | IgG1, κ | Recombinant human EGFR protein | |
DMAb-3322-FY | GFR450 | Mouse | Human | IgG2a, κ | Recombinant extracellular domain of human EGFR protein | |
DMAb-3323-FY | GT461 | Mouse | Human | IgG2a | Recombinant protein encompassing a sequence within the C-terminus region of human EGFR. The exact sequence is proprietary | |
DMAb-3324-FY | H9B4 | Mouse | Human | IgG1 | Purified EGFR from A431 cells | |
DMAb-3325-FY | ICR61 | Rat | IgG2b | |||
DMAb-3326-FY | M9020201 | Mouse | IgG1 | EGFR antibody was raised in mouse using human A431 membrane proteins as the immunogen | ||
DMAb-3327-FY | Matuzumab | Rabbit | Human | IgG | Domain III of the extracellular domain of human EGRF | |
DMAb-3328-FY | me1B3 | Mouse | Human | IgG1, κ | ||
DMAb-3329-FY | MM0256-5S21 | Mouse | Human | IgG2 | ||
DMAb-3330-FY | R19/48MIX | Mouse | Human | IgG1 | Purified extracellular and cytoplasmic domains of human recombinant EGFR protein | |
DMAb-3331-FY | REA688 | Human | Human | IgG1 | ||
DMAb-3332-FY | SB41a | Mouse | Human | IgG2a | Recombinant protein corresponding to human EGFR |
There are currently no customer reviews or questions for Anti-EGFR DNA-encoded mAb (DMAb), pVAX1 (DMAb-0771-CQ). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION